- Home
- LIEN vs JUNS Comparison
LIEN vs JUNS Comparison
Compare LIEN & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIEN
- JUNS
- Stock Information
- Founded
- LIEN 2021
- JUNS 2015
- Country
- LIEN United States
- JUNS United States
- Employees
- LIEN N/A
- JUNS N/A
- Industry
- LIEN
- JUNS
- Sector
- LIEN
- JUNS
- Exchange
- LIEN NYSE
- JUNS NYSE
- Market Cap
- LIEN 264.8M
- JUNS 281.4M
- IPO Year
- LIEN 2022
- JUNS 2024
- Fundamental
- Price
- LIEN $11.56
- JUNS $0.76
- Analyst Decision
- LIEN
- JUNS
- Analyst Count
- LIEN 0
- JUNS 0
- Target Price
- LIEN N/A
- JUNS N/A
- AVG Volume (30 Days)
- LIEN 10.3K
- JUNS 121.4K
- Earning Date
- LIEN 05-08-2025
- JUNS 05-11-2025
- Dividend Yield
- LIEN 12.03%
- JUNS N/A
- EPS Growth
- LIEN N/A
- JUNS N/A
- EPS
- LIEN 0.67
- JUNS N/A
- Revenue
- LIEN $12,681,914.00
- JUNS N/A
- Revenue This Year
- LIEN $71.81
- JUNS N/A
- Revenue Next Year
- LIEN $113.93
- JUNS N/A
- P/E Ratio
- LIEN $17.20
- JUNS N/A
- Revenue Growth
- LIEN 22.94
- JUNS N/A
- 52 Week Low
- LIEN $8.38
- JUNS $0.55
- 52 Week High
- LIEN $13.38
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- LIEN N/A
- JUNS N/A
- Support Level
- LIEN N/A
- JUNS N/A
- Resistance Level
- LIEN N/A
- JUNS N/A
- Average True Range (ATR)
- LIEN 0.00
- JUNS 0.00
- MACD
- LIEN 0.00
- JUNS 0.00
- Stochastic Oscillator
- LIEN 0.00
- JUNS 0.00
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.